These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38690943)

  • 1. TRPV1 signaling of perirenal adipose tissue promotes DOCA-Salt-induced hypertension and kidney injury.
    Hua D; Huang W; Huang W; Xie Q; Tang L; Wu X; Gao M; Xu T; Zhang Y; Li P; Sun W; Kong X
    J Hypertens; 2024 Aug; 42(8):1409-1420. PubMed ID: 38690943
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the monocyte chemoattractant protein-1/C-C chemokine receptor 2 signaling pathway in transient receptor potential vanilloid type 1 ablation-induced renal injury in salt-sensitive hypertension.
    Wang Y; Zhu M; Xu H; Cui L; Liu W; Wang X; Shen S; Wang DH
    Exp Biol Med (Maywood); 2015 Sep; 240(9):1223-34. PubMed ID: 25585624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of TRPV1 against renal fibrosis via inhibition of TGF-β/Smad signaling in DOCA-salt hypertension.
    Wang Y; Wang DH
    Mol Med; 2011; 17(11-12):1204-12. PubMed ID: 21792478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aggravated renal inflammatory responses in TRPV1 gene knockout mice subjected to DOCA-salt hypertension.
    Wang Y; Wang DH
    Am J Physiol Renal Physiol; 2009 Dec; 297(6):F1550-9. PubMed ID: 19794112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of transient receptor potential vanilloid type 1 receptors exaggerates renal damage in deoxycorticosterone acetate-salt hypertension.
    Wang Y; Babánková D; Huang J; Swain GM; Wang DH
    Hypertension; 2008 Aug; 52(2):264-70. PubMed ID: 18606907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of transient receptor potential vanilloid type 1 and C-C chemokine receptor 2 in renal injury induced by salt-sensitive hype].
    Zhu FY; Liu WH; Wang XX; Cui L; Shen S; Zhu MJ; Wang YP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Oct; 36(5):488-95. PubMed ID: 25360645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of TRPV4 by dietary apigenin antagonizes renal fibrosis in deoxycorticosterone acetate (DOCA)-salt-induced hypertension.
    Wei X; Gao P; Pu Y; Li Q; Yang T; Zhang H; Xiong S; Cui Y; Li L; Ma X; Liu D; Zhu Z
    Clin Sci (Lond); 2017 Apr; 131(7):567-581. PubMed ID: 28143892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
    Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L
    Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution, Morphological Characterization, and Resiniferatoxin-Susceptibility of Sensory Neurons That Innervate Rat Perirenal Adipose Tissue.
    Liu BX; Qiu M; Zong PY; Chen XG; Zhao K; Li Y; Li P; Sun W; Kong XQ
    Front Neuroanat; 2019; 13():29. PubMed ID: 30930754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Medullary Overexpression of Sphingosine-1-Phosphate Receptor 1 Transgene Attenuates Deoxycorticosterone Acetate (DOCA)-Salt Hypertension.
    Hu G; Xie D; Chen C; Wang W; Li PL; Ritter JK; Li N
    Am J Hypertens; 2023 Aug; 36(9):509-516. PubMed ID: 37171128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resting Afferent Renal Nerve Discharge and Renal Inflammation: Elucidating the Role of Afferent and Efferent Renal Nerves in Deoxycorticosterone Acetate Salt Hypertension.
    Banek CT; Knuepfer MM; Foss JD; Fiege JK; Asirvatham-Jeyaraj N; Van Helden D; Shimizu Y; Osborn JW
    Hypertension; 2016 Dec; 68(6):1415-1423. PubMed ID: 27698066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted afferent renal denervation reduces arterial pressure but not renal inflammation in established DOCA-salt hypertension in the rat.
    Banek CT; Gauthier MM; Baumann DC; Van Helden D; Asirvatham-Jeyaraj N; Panoskaltsis-Mortari A; Fink GD; Osborn JW
    Am J Physiol Regul Integr Comp Physiol; 2018 Jun; 314(6):R883-R891. PubMed ID: 29513561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide attenuates renal damage by limiting inflammatory responses in DOCA-salt hypertension.
    Zhang J; Zhu M; Zhang S; Xie S; Gao Y; Wang Y
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107035. PubMed ID: 33045566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
    Arai K; Morikawa Y; Ubukata N; Tsuruoka H; Homma T
    J Pharmacol Exp Ther; 2016 Sep; 358(3):548-57. PubMed ID: 27384074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detrimental role of sphingosine kinase 1 in kidney damage in DOCA-salt hypertensive model: evidence from knockout mice.
    Lyu B; Wang W; Ji XY; Ritter JK; Li N
    BMC Nephrol; 2020 May; 21(1):173. PubMed ID: 32393187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Inflammation in DOCA-Salt Hypertension.
    Banek CT; Gauthier MM; Van Helden DA; Fink GD; Osborn JW
    Hypertension; 2019 May; 73(5):1079-1086. PubMed ID: 30879356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ablation of TRPV1-positive nerves exacerbates salt-induced hypertension and tissue injury in rats after renal ischemia-reperfusion via infiltration of macrophages.
    Yu SQ; Ma S; Wang DH
    Clin Exp Hypertens; 2021 Apr; 43(3):254-262. PubMed ID: 33327798
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophage-dependent impairment of α
    Mui RK; Fernandes RN; Garver HG; Van Rooijen N; Galligan JJ
    Am J Physiol Heart Circ Physiol; 2018 Apr; 314(4):H863-H877. PubMed ID: 29351460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats.
    Wang F; Sun Y; Luo R; Lu X; Yang B; Yang T
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F647-F653. PubMed ID: 32799674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
    Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
    Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.